Trial of VLTS-589 in Subjects With Intermittent Claudication
- Conditions
- Intermittent ClaudicationPeripheral Vascular Disease
- Registration Number
- NCT00068133
- Lead Sponsor
- Valentis
- Brief Summary
The purpose of this study is to evaluate the safety and tolerability of VLTS-589 compared with placebo, administered bilaterally to the lower extremities, in subjects with intermittent claudication and to determine the effect of VLTS-589 in peak walking time (PWT) for subjects receiving VLTS-589 compared with subjects receiving placebo.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 100
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (20)
Prairie Heart Institution at St. John's Hospital
🇺🇸Springfield, Illinois, United States
New Orleans Center for Clinical Research
🇺🇸New Orleans, Louisiana, United States
University of Michigan Health Systems
🇺🇸Ann Arbor, Michigan, United States
Dartmouth-Hitchcock Medical Center
🇺🇸Lebanon, New Hampshire, United States
Androscoggin Cardiology Associates
🇺🇸Auburn, Maine, United States
Cardiology Pc
🇺🇸Birmingham, Alabama, United States
Heart Specialists of Sarasota Clinical Research Center
🇺🇸Sarasota, Florida, United States
American Cardiovascular Research Institute
🇺🇸Atlanta, Georgia, United States
Rush Presbyterian St. Luke's Medical Center
🇺🇸Chicago, Illinois, United States
The Care Group
🇺🇸Indianapolis, Indiana, United States
Daniel Gottleib, MD
🇺🇸Seattle, Washington, United States
Minneapolis Heart Institution Foundation
🇺🇸Minneapolis, Minnesota, United States
Duke Clinical Research Institute
🇺🇸Durham, North Carolina, United States
University of Oklahoma Health Science Center
🇺🇸Oklahoma City, Oklahoma, United States
Vanderbilt University Medical Center
🇺🇸Nashville, Tennessee, United States
The Methodist Hospital
🇺🇸Houston, Texas, United States
Arizona Heart Institute
🇺🇸Phoenix, Arizona, United States
St. Vincent's Hospital
🇺🇸New York, New York, United States
Access Clinical Trials-Cardiovascular Research
🇺🇸Beverly Hills, California, United States
Jacksonville Heart Center
🇺🇸Jacksonville, Florida, United States